A review ofimaging genetics in Alzheimer's disease

J Clin Neurosci. 2022 Jun:100:155-163. doi: 10.1016/j.jocn.2022.04.017. Epub 2022 Apr 26.

Abstract

Determining the association between genetic variation and phenotype is a key step to study the mechanism of Alzheimer's disease (AD), laying the foundation for studying drug therapies and biomarkers. AD is the most common type of dementia in the aged population. At present, three early-onset AD genes (APP, PSEN1, PSEN2) and one late-onset AD susceptibility gene apolipoprotein E (APOE) have been determined. However, the pathogenesis of AD remains unknown. Imaging genetics, an emerging interdisciplinary field, is able to reveal the complex mechanisms from the genetic level to human cognition and mental disorders via macroscopic intermediates. This paper reviews methods of establishing genotype-phenotype to explore correlations, including sparse canonical correlation analysis, sparse reduced rank regression, sparse partial least squares and so on. We found that most research work did poorly in supervised learning and exploring the nonlinear relationship between SNP-QT.

Keywords: Alzheimer's disease; Imaging genomics; Sparse canonical correlation analysis; Sparse reduced-rank regression.

Publication types

  • Review

MeSH terms

  • Aged
  • Alzheimer Disease* / diagnostic imaging
  • Alzheimer Disease* / genetics
  • Amyloid beta-Protein Precursor / genetics
  • Apolipoproteins E / genetics
  • Genetic Predisposition to Disease / genetics
  • Humans

Substances

  • Amyloid beta-Protein Precursor
  • Apolipoproteins E